- Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma. Tulpule, A., Rarick, M.U., Kolitz, J., Bernstein, J., Myers, A., Buchanan, L.A., Espina, B.M., Traynor, A., Letzer, J., Justice, G.R., McDonald, D., Roberts, L., Boswell, W., Nathwani, B., Levine, A.M. Ann. Oncol. (2001)